Husna Madoramae

Ms. Husna Madoramae


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2025 in Molecules
Verified
Journal Article
Open access
PDF file
HMHusna Madoramae
Husna Madoramae
MLMonthon Lertcanawanichakul
Monthon Lertcanawanichakul
Red palm oil (RPO) is a rich source of bioactive compounds, including carotenoids, tocopherols, tocotrienols, and polyphenols, which contribute to its potent antioxidant and anti-inflammatory properties. This review summarizes the current understanding of RPO composition, bioactivity, and potential applications in health and cosmetics. Current preclinical and small-scale clinical studies suggest that RPO bioactives can mitigate oxidative stress, modulate inflammatory pathways, and improve skin barrier function. Strategies to enhance stability and bioavailability, such as microencapsulation and formulation into emulsions or liposomes, are also discussed. The manuscript highlights the potential of RPO as a natural functional ingredient in dietary, nutraceutical, and cosmetic products. Comprehensive evaluation of these bioactive compounds provides insights for future research and practical applications in promoting human health.

15 January 2026 in Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
MLMonthon Lertcanawanichakul
Monthon Lertcanawanichakul
PBPhuangthip Bhoopong
Phuangthip Bhoopong
HMHusna Madoramae
Husna Madoramae
TSTuanhawanti Sahabuddeen
Tuanhawanti Sahabuddeen
Probiotics and microbiome-based therapeutics are increasingly used to prevent antibiotic-associated diarrhea (AAD) and support gut microbiota health across children, adults, and elderly populations. Evidence synthesized in this narrative review from randomized controlled trials and meta-analyses (>20,000 participants) suggests that early probiotic administration, particularly Lactobacillus rhamnosus GG, Bifidobacterium species, multistrain formulations, and Saccharomyces boulardii, is associated with a 30–40% relative reduction in AAD incidence across heterogeneous studies, with absolute risk reductions of approximately 5–12% depending on baseline risk, strain, dose, and timing. Probiotics are generally well tolerated, with mild gastrointestinal adverse effects reported in 3–5% of users and rare serious events mainly in immunocompromised individuals. However, heterogeneity in formulations, populations, and limited long-term real-world data underscores the need for further pharmacoepidemiological studies, microbiome surveillance, and evaluation of antimicrobial resistance implications.

18 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MLMonthon Lertcanawanichakul
Monthon Lertcanawanichakul
TSTuanhawanti Sahabuddeen
Tuanhawanti Sahabuddeen
HMHusna Madoramae
Husna Madoramae
SJSupachai Jankhlay
Supachai Jankhlay
Red Palm Oil (RPO), extracted from the mesocarp of Elaeis guineensis, is rich in bioactive compounds including carotenoids (β-carotene, α-carotene, lycopene), tocopherols, tocotrienols, squalene, and phytosterols. These compounds exhibit antioxidant, anti-inflammatory, antimicrobial, and skin-protective activities, highlighting RPO as a promising natural ingredient for cosmeceutical applications. This study integrates a literature review with experimental evaluation of three RPO types—Premium Olein, Crude Palm Oil A, and Premium Stearin Butter—assessing their antioxidant capacity, antimicrobial effects, and suitability for topical formulations. Experimental results were compared with literature values, showing consistent trends and confirming RPO’s cosmeceutical potential. Premium Stearin Butter exhibited the highest bioactive activity, particularly in radical scavenging and solvent-assisted antimicrobial effects. RPO can be incorporated into moisturizers, anti-aging serums, sunscreens, lip balms, and eye creams, with careful attention to color, odor, stability, and delivery systems. The findings support sustainable cosmeceutical development and add economic value to Thailand’s palm oil industry. Further studies on individual bioactive compounds, advanced delivery systems, clinical evaluation, and market acceptance are recommended.

27 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MLMonthon Lertcanawanichakul
Monthon Lertcanawanichakul
PBPhuangthip Bhoopong
Phuangthip Bhoopong
TSTuanhawanti Sahabuddeen
Tuanhawanti Sahabuddeen
PPPatchara Pedpradab
Patchara Pedpradab
HMHusna Madoramae
Husna Madoramae
Nuttapon SongnakaNuttapon Songnaka
Nuttapon Songnaka
Marine-derived Streptomyces have emerged as one of the most prolific microbial resources for structurally diverse and pharmacologically significant natural products. Adaptation to highly competitive marine ecological niches, including deep-sea sediments, hydrothermal vents, mangrove ecosystems, marine invertebrates, and saline habitats, has driven the evolution of specialized biosynthetic systems capable of generating chemically complex secondary metabolites. Recent advances in genome sequencing, bioinformatics, metabolomics, synthetic biology, and artificial intelligence-assisted discovery pipelines have significantly expanded understanding of cryptic biosynthetic gene clusters (BGCs) encoded within marine actinomycete genomes. These BGCs produce structurally diverse metabolites including polyketides, non-ribosomal peptides, ribosomally synthesized and post-translationally modified peptides (RiPPs), terpenoids, alkaloids, and hybrid metabolites with potent antibacterial, antifungal, antiviral, antiparasitic, anti-inflammatory, and anticancer activities. Nevertheless, despite rapid technological progress, major translational limitations remain, including low cultivation efficiency, silent pathway expression, rediscovery of known compounds, metabolite yield instability, dereplication bottlenecks, and insufficient ecological interpretation. This critical review comprehensively discusses the biosynthetic diversity of marine Streptomyces-derived metabolites with emphasis on biosynthetic pathways, enzymatic tailoring reactions, genome mining strategies, metabolomics-guided discovery, synthetic biology approaches, and pharmaceutical applications. In addition, current limitations and future perspectives in marine natural product research are critically evaluated to highlight the transition from descriptive omics-driven exploration toward functionally validated and translationally relevant drug discovery.

22 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
HMHusna Madoramae
Husna Madoramae
TSTuanhawanti Sahabuddeen
Tuanhawanti Sahabuddeen
MLMonthon Lertcanawanichakul
Monthon Lertcanawanichakul
Background: Methicillin-resistant Staphylococcus aureus (MRSA) remains a significant global health threat due to its multidrug resistance, biofilm formation, and high viru-lence, which collectively limit the efficacy of conventional antibiotics and drive the need for alternative therapeutic approaches. Objectives: To review the current progress in antimicrobial peptides (AMPs) as therapeutic candidates against MRSA, focusing on mechanisms of action, resistance circumvention, formulation strategies, translational challenges, and future perspectives. Methods: Narrative review of recent studies on AMPs targeting MRSA, including peptide engineering, chemical modifications, and de-livery approaches to enhance stability, potency, and specificity. Results: AMPs exert multifaceted effects such as membrane disruption, inhibition of intracellular targets, interference with biofilm formation, and modulation of host immune responses. Their pleiotropic mechanisms reduce the likelihood of resistance development, and engi-neering strategies including cyclization, stapling, and conjugation with lipids or nano-particles improve pharmacokinetics and target specificity. Conclusions: AMPs represent promising therapeutic alternatives against MRSA. Understanding their mechanisms, optimizing peptide design, and developing effective delivery strategies are essential for clinical translation in the post-antibiotic era.

15 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
TSTuanhawanti Sahabuddeen
Tuanhawanti Sahabuddeen
HMHusna Madoramae
Husna Madoramae
MLMonthon Lertcanawanichakul
Monthon Lertcanawanichakul
Background: The development of natural starter cultures with antibacterial and antioxidant properties is gaining interest for improving food fermentation and safety. Enterococcus faecalis BD8, isolated from traditional fermented fish (bòo-doo), exhibits strong bioactivity. Methods: This study identified E. faecalis BD8 using MALDI-TOF mass spectrometry and assessed its antibacterial activity against Salmonella spp., Escherichia coli TISTR884, and Staphylococcus aureus TISTR512, as well as spoilage microorganisms. Antioxidant properties were measured using DPPH and ABTS assays. The bacterium was incorporated into rice flour-based starter culture powder via freeze-drying. Viability during storage and its application in fermented fish (Pla Som) were evaluated, along with sensory attributes. Results: E. faecalis BD8 exhibited significant antibacterial activity, with inhibition zones ranging from 16 to 22 mm, particularly against S. aureus (p < 0.05). Antioxidant activity was moderate, with IC50 values of 0.45 mg/mL (DPPH) and 0.32 mg/mL (ABTS). The starter culture powder retained 82% bacterial viability after 30 days at 4°C. When applied in Pla Som, fermentation was completed in 48 hours, reducing traditional processing time. Sensory evaluation showed favorable ratings for appearance and aroma, though texture required optimization. Conclusion: The rice flour-based E. faecalis BD8 starter culture demonstrates potential for fermented food applications, enhancing safety and efficiency. Further optimization is needed to improve sensory characteristics.